No association of postoperative opioid usage with long-term surgery outcomes in patients with liver cancer: a population-based retrospective cohort study

医学 回顾性队列研究 危险系数 类阿片 置信区间 倾向得分匹配 比例危险模型 队列 队列研究 内科学 外科 肝细胞癌 受体
作者
Pin-Hung Yeh,Han‐Wei Yeh,Shun‐Fa Yang,Yu‐Hsun Wang,Ming‐Chih Chou,Ping‐Kun Tsai,Chao‐Bin Yeh
出处
期刊:Pain [Lippincott Williams & Wilkins]
卷期号:164 (4): 848-854 被引量:5
标识
DOI:10.1097/j.pain.0000000000002776
摘要

ABSTRACT: Hepatocellular carcinoma (HCC) is a fatal cancer worldwide, and surgical resection remains the standard treatment. Postoperative opioid prescription has been believed to affect cancer recurrence through complex biological pathways. We conducted a retrospective cohort study using the Longitudinal Health Insurance Database of Taiwan to evaluate the relationship between postoperative opioid use and long-term surgical outcomes of patients with HCC. This study had a retrospective cohort design. In total, 812 patients older than 20 years who underwent hepatectomy because of HCC were included. The exposure group comprised patients who used opioids during hospitalization postoperatively. The comparison group included those who never used opioids during hospitalization postoperatively. A Cox proportional hazards model was used to evaluate the overall survival or recurrence-free survival rate between the opioid group and the nonopioid group. A total of 530 patients received opioids postoperatively and 282 patients did not. The hazard ratios of overall survival and recurrence-free survival were 1.10 (95% confidence interval [CI], 0.85-1.41) and 1.15 (95% CI, 0.91-1.46), respectively. Total postoperative opioids were converted into oral morphine milligram equivalents and then divided into 3 equal subgroups: low dose, <40 mg; medium dose, 40 to 144 mg; and high dose, ≥145 mg. The hazard ratios of overall survival were 0.88 (95% CI, 0.63-1.24) for the low-dose group, 1.27 (95% CI, 0.92-1.74) for the medium-dose group, and 1.14 (95% CI, 0.83-1.58) for the high-dose group. Postoperative opioids do not affect overall and recurrence-free survival in patients undergoing hepatectomy or liver transplantation because of HCC. Cancer recurrence should not be a clinical concern regarding postoperative opioid prescription.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
大个的应助被个性的山芙采纳,获得10
2秒前
李晓丽完成签到 ,获得积分10
2秒前
2秒前
2秒前
Tning完成签到,获得积分10
2秒前
Eii完成签到 ,获得积分10
3秒前
今后的应助被不要命的小火龙采纳,获得30
3秒前
烟花的应助被不要命的小火龙采纳,获得10
3秒前
儒雅青梦发布了新的文献求助10
3秒前
Ava的应助被不要命的小火龙采纳,获得10
3秒前
liu完成签到,获得积分10
3秒前
3秒前
今后的应助被不要命的小火龙采纳,获得30
4秒前
4秒前
4秒前
4秒前
传奇3的应助被不要命的小火龙采纳,获得30
4秒前
超级无敌发布了新的文献求助10
4秒前
慕青的应助被不要命的小火龙采纳,获得30
5秒前
Jasper的应助被不要命的小火龙采纳,获得30
5秒前
1234发布了新的文献求助10
5秒前
6秒前
Anonymous完成签到,获得积分0
7秒前
molihuakai的应助被WYL采纳,获得10
7秒前
8秒前
LIUDAN发布了新的文献求助10
8秒前
ertredffg完成签到,获得积分10
8秒前
基金中中中完成签到,获得积分10
9秒前
FXQ完成签到,获得积分10
10秒前
ZHENG发布了新的文献求助10
10秒前
韭菜馅发布了新的文献求助10
10秒前
11秒前
Lsmile完成签到 ,获得积分10
12秒前
论高等数学的无用性完成签到 ,获得积分10
12秒前
Hugo发布了新的文献求助10
12秒前
taoshiren发布了新的文献求助10
12秒前
丰富俊驰完成签到 ,获得积分10
13秒前
didi完成签到 ,获得积分10
13秒前
NexusExplorer的应助被FaFa采纳,获得10
13秒前
li完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189302
求助须知:如何正确求助?哪些是违规求助? 9576666
关于积分的说明 21849295
捐赠科研通 7787245
什么是DOI,文献DOI怎么找? 3435521
关于科研通互助平台的介绍 2559748
邀请新用户注册赠送积分活动 2482509